Murine prostate cancer inhibition by dietary phytochemicals - Curcumin and phenyethylisothiocyanate

Pharmaceutical Research

Volumn 25, Issue 9, 2008, Pages 2181-2189

  Barve, Avantika ^a   Khor, Tin Oo ^a   Hao, Xingpei ^a   Keum, Young Sam ^a   Yang, Chung S ^a   Reddy, Bandaru ^a   Kong, Ah Ng Tony ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Cancer chemoprevention; Curcumin; PEITC; Prostate cancer; TRAMP

Indexed keywords

CURCUMIN; PHENYLETHYLISOTHIOCYANATE; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; CASPASE 3; CELL PROLIFERATION; CURCUMIN; DIET; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; FORKHEAD TRANSCRIPTION FACTORS; ISOTHIOCYANATES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 49549098608     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-008-9574-7     Document Type: Article

References (22)

1. L. Denis M. S. Morton K. Griffiths 1999 Diet and its preventive role in prostatic disease Eur. Urol 35 377 387
2. C. Abate-Shen M. M. Shen 2002 Mouse models of prostate carcinogenesis Trends. Genet 18 S1 S5
3. J. R. Gingrich R. J. Barrios R. A. Morton B. F. Boyce F. J. DeMayo M. J. Finegold 1996 Metastatic prostate cancer in a transgenic mouse Cancer. Res 56 4096 102
4. N. M. Greenberg F. J. DeMayo P. C. Sheppard R. Barrios R. Lebovitz M. Finegold 1994 The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice Mol. Endocrinol 8 230 239
5. D. Xiao S. V. Singh 2002 Phenethyl isothiocyanate-induced apoptosis in p53-deficient PC-3 human prostate cancer cell line is mediated by extracellular signal-regulated kinases Cancer Res 62 3615 619
6. C. Huang W. Y. Ma J. Li S. S. Hecht Z. Dong 1998 Essential role of p53 in phenethyl isothiocyanate-induced apoptosis Cancer Res 58 4102 4106
7. Y. R. Chen J. Han R. Kori A. N. Kong T. H. Tan 2002 Phenylethyl isothiocyanate induces apoptotic signaling via suppressing phosphatase activity against c-Jun N-terminal kinase J. Biol. Chem 277 39334 39342
8. D. Xiao Y. Zeng S. Choi K. L. Lew J. B. Nelson S. V. Singh 2005 Caspase-dependent apoptosis induction by phenethyl isothiocyanate, a cruciferous vegetable-derived cancer chemopreventive agent, is mediated by Bak and Bax Cli.n Cancer Res 11 2670 2679
9. C. Xu G. Shen X. Yuan J. H. Kim A. Gopalakrishnan Y. S. Keum 2006 ERK and JNK signaling pathways are involved in the regulation of activator protein 1 and cell death elicited by three isothiocyanates in human prostate cancer PC-3 cells Carcinogenesis 27 437 445
10. O. P. Sharma 1976 Antioxidant activity of curcumin and related compounds Biochem. Pharmacol 25 1811 1812
11. M. T. Huang Z. Y. Wang C. A. Georgiadis J. D. Laskin A. H. Conney 1992 Inhibitory effects of curcumin on tumor initiation by benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene Carcinogenesis 13 2183 186
12. M. T. Huang Y. R. Lou W. Ma H. L. Newmark K. R. Reuhl 1994 Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice Cancer Res 54 5841 5847
13. D. Deeb H. Jiang X. Gao M. S. Hafner H. Wong G. Divine 2004 Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation Mol. Cancer Ther 3 803 812
14. J. H. Hong K. S. Ahn E. S. Bae S. S. Jeon H. Y. Choi 2006 The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo Prostate Cancer Prostatic Dis 9 147 152
15. T. O. Khor Y. S. Keum W. Lin J. H. Kim R. Hu G. Shen 2006 Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice Cancer Res 66 613 621
16. J. H. Kim C. Xu Y. S. Keum B. S. Reddy A. Conney A. N. Kong 2006 Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with beta-phenylethyl isothiocyanate and curcumin Carcinogenesis 27 475 482
17. J. H. Park J. E. Walls J. J. Galvez M. Kim C. Abate-Shen M. M. Shen 2002 Prostatic intraepithelial neoplasia in genetically engineered mice Am. J. Pathol 161 727 735
18. S. Gupta K. Hastak N. Ahmad J. S. Lewin H. Mukhtar 2001 Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols Proc. Natl. Acad. Sci. U S A 98 10350 10355
19. M. H. Aziz M. Nihal V. X. Fu D. F. Jarrard N. Ahmad 2006 Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3-kinase/Akt pathway and Bcl-2 family proteins Mol. Cancer Ther 5 1335 1341
20. N. Pommery J. P. Henichart 2005 Involvement of PI3K/Akt pathway in prostate cancer-potential strategies for developing targeted therapies Mini Rev. Med. Chem 5 1125 1132
21. N. Pommery J. P. Henichart 2005 Involvement of PI3K/Akt pathway in prostate cancer. Potential strategies for developing targeted therapies Ann. Pharm. Fr 63 69 75
22. S. Shukla G. T. Maclennan S. R. Marengo M. I. Resnick S. Gupta 2005 Constitutive activation of P I3 K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model Prostate 64 224 239